Expands the definition of epinephrine devices to include epinephrine nasal sprays

• Democratic6
• Republican1

◆ The sponsor's argument

Why Andrew Gounardes says this is needed

According to the Centers for Disease Control and Prevention, nearly 1 in 13 children suffer from a food allergy. The National Institutes of Health has found that food allergies contribute to many deaths per year and thousands of hospitalizations. Epinephrine is a lifesaving drug that can reverse anaphylactic shock, and those who live with severe food allergies rely on epinephrine auto-injectors to reverse anaphylactic symptoms in emergency situations. New York State has long been a leader in enacting laws to improve access to epinephrine and training opportu- nities for those who may need to assist in administering epinephrine. In August 2024, the Food and Drug Administration approved a first-of-its kind epinephrine nasal spray for the emergency treatment of anaphylactic reactions. This nasal spray will help to make epinephrine more accessi- ble to those who need it, particularly for people who are fearful of needles. This legislation amends the definition of epinephrine devices used in New York State law to include other forms of epinephrine that may become available. This legislation also adjusts existing laws that regulate the training and stocking of epinephrine devices, ensuring that our laws will continue to make epinephrine as accessible as possible, whether through an auto-injector device or another form.

This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.